Related Articles
Combination therapy with interferon α and β to chronic hepatitis C
Development of hepatocellular carcinoma in patients with chronic hepatitis C more than 10 years after sustained virological response to interferon therapy
Absence of differences in the recurrence rates of hepatitis C virus‑associated hepatocellular carcinoma between direct‑acting antivirals and interferon‑based treatments: A multicenter study
Long-term evaluation of interferon therapy in hepatitis C virus-associated cirrhosis: does IFN prevent development of hepatocellular carcinoma?
Histological changes in patients who developed hepatocellular carcinoma after hepatitis C virus eradication by interferon‑based therapy